You are here

Engine Biosciences to raise additional funding next year

The process of discovering and developing a drug traditionally costs close to US$2 billion on average, and over 10 years of R&D, says Engine Biosciences CEO Jeffrey Lu.


A BIOTECH startup that only this year raised what is believed to be the largest round of seed funding in South-east Asia has plans to raise additional funding as early as next year, The Business Times has learnt.

Engine Biosciences, a Singapore-based company that has...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to